Skip to main content

UNITED CAPITAL FINANCIAL ADVISORS, LLC

Position in NVO — Novo Nordisk A S

CIK 1463217 IRVING, TX

Position in NVO

as of Jun 30, 2026 · filed Aug 17, 2026
Position Value
$47,972,695
+$9,288,837 QoQ
Shares Held
1,000,682
-4.9% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#57
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

UNITED CAPITAL FINANCIAL ADVISORS, LLC holds $392,709,829 across 14 Drug Manufacturers - General names. NVO ranks #4 (12.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 NVO
Novo Nordisk A S
This page
1,000,682 $47,972,695

All Filings in NVO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $47,972,695 1,000,682
2026-03-31 $38,683,858 1,052,622
2025-12-31 $32,988,200 648,353
2025-09-30 $35,391,910 637,807
2025-06-30 $38,140,521 552,601
2025-03-31 $40,017,438 576,288
2024-12-31 $30,984,834 360,205
2024-09-30 $50,113,824 420,877
2024-06-30 $63,371,849 443,967
2024-03-31 $61,776,064 481,122
2023-12-31 $56,122,762 542,511
2023-09-30 $87,446,812 961,588
2023-06-30 $90,882,757 561,594
2023-03-31 $94,647,560 594,744
2022-12-31 $84,946,015 627,649
2022-09-30 $65,711,165 659,552
2022-06-30 $77,070,559 691,650
2022-03-31 $84,877,180 764,315
2021-12-31 $90,027,392 803,816
2021-09-30 $78,746,633 820,192
2021-06-30 $71,043,661 848,080
2021-03-31 $55,704,224 826,227
2020-12-31 $58,841,151 842,393
2020-09-30 $58,993,560 849,684
2020-06-30 $59,712,128 911,914
2020-03-31 $51,381,723 853,517